Early proteostasis of caveolins synchronizes trafficking, degradation, and oligomerization to prevent toxic aggregation
Journal of Cell Biology · 04.09.2023 · 222 (9)
DOI: 10.1083/jcb.202204020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, online erschienen am 01.08.2023. Verfasst von Frederic Morales-Paytuví und 9 weiteren Autor:innen. Beteiligte Einrichtung: Lipid Trafficking and Disease Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Hauptthemen laut MEDLINE: Caveolins, Proteostasis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Centres de Recerca de Catalunya, Generalitat de Catalunya.
Abstract (Originalsprache)
Caveolin-1 (CAV1) and CAV3 are membrane-sculpting proteins driving the formation of the plasma membrane (PM) caveolae. Within the PM mosaic environment, caveola assembly is unique as it requires progressive oligomerization of newly synthesized caveolins while trafficking through the biosynthetic-secretory pathway. Here, we have investigated these early events by combining structural, biochemical, and microscopy studies. We uncover striking trafficking differences between caveolins, with CAV1 rapidly exported to the Golgi and PM while CAV3 is initially retained in the endoplasmic reticulum and laterally moves into lipid droplets. The levels of caveolins in the endoplasmic reticulum are controlled by proteasomal degradation, and only monomeric/low oligomeric caveolins are exported into the cis-Golgi with higher-order oligomers assembling beyond this compartment. When any of those early proteostatic mechanisms are compromised, chemically or genetically, caveolins tend to accumulate along the secretory pathway forming non-functional aggregates, causing organelle damage and triggering cellular stress. Accordingly, we propose a model in which disrupted proteostasis of newly synthesized caveolins contributes to pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lipid Trafficking and Disease Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
- Institute for Molecular Bioscience (IMB), The University of Queensland (UQ) , Brisbane, Australia.
- Department of Biomedical Sciences, Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain.
- Centre for Microscopy and Microanalysis (CMM), The University of Queensland (UQ), Brisbane, Australia.
- Institució Catalana de Recerca i Estudis Avançats (ICREA) , Barcelona, Spain.
ORCID-Profile: Frederic Morales-Paytuví, Alba Fajardo, Carles Ruiz-Mirapeix, James Rae, Francesc Tebar, Marta Bosch, Carlos Enrich, Brett M Collins, Robert G Parton, Albert Pol
Förderung
- Ministerio de Ciencia e Innovación
- Centres de Recerca de Catalunya
- Generalitat de Catalunya
- National Health and Medical Research Council
- Australian Research Council
- Foreign portfolio investment
- European Union
- European Research Council
Zitieren
APA
Morales-Paytuví, F., Fajardo, A., Ruiz-Mirapeix, C., Rae, J., Tebar, F., Bosch, M., Enrich, C., Collins, B. M., Parton, R. G., & Pol, A. (2023). Early proteostasis of caveolins synchronizes trafficking, degradation, and oligomerization to prevent toxic aggregation. Journal of Cell Biology, 222(9). https://doi.org/10.1083/jcb.202204020
Vancouver
Morales-Paytuví F, Fajardo A, Ruiz-Mirapeix C, Rae J, Tebar F, Bosch M, et al. Early proteostasis of caveolins synchronizes trafficking, degradation, and oligomerization to prevent toxic aggregation. Journal of Cell Biology. 2023;222(9). doi:10.1083/jcb.202204020
BibTeX
@article{MoralesPaytuv2023,
author = {Morales-Paytuví, Frederic and Fajardo, Alba and Ruiz-Mirapeix, Carles and Rae, James and Tebar, Francesc and Bosch, Marta and Enrich, Carlos and Collins, Brett M and Parton, Robert G and Pol, Albert},
title = {Early proteostasis of caveolins synchronizes trafficking, degradation, and oligomerization to prevent toxic aggregation},
journal = {Journal of Cell Biology},
year = {2023},
volume = {222},
number = {9},
doi = {10.1083/jcb.202204020}
}
EUVIMED